Gritstone Oncology, Inc. License Agreements
3 Contracts & Agreements
- Fourth Amendment to the License Agreement between Gritstone bio, Inc. and MIL 21E, LLC, effective as of June 30, 2022 (Filed With SEC on August 4, 2022)
- Amendment Number One to License Agreement, dated as of July 20, 2018, by and among Gritstone Oncology, Inc., Arbutus Biopharma Corporation and its subsidiary Protiva... (Filed With SEC on August 23, 2018)
- License Agreement, dated as of October 16, 2017, by and among Gritstone Oncology, Inc., Arbutus Biopharma Corporation and its subsidiary Protiva Biotherapeutics Inc (Filed With SEC on August 23, 2018)